US Stock MarketDetailed Quotes
RDHL Redhill Biopharma
- 7.290
- +0.300+4.29%
Close Nov 15 16:00 ET
- 7.070
- -0.220-3.02%
Post 20:01 ET
9.29MMarket Cap-24P/E (TTM)
7.299High6.700Low11.71KVolume7.054Open6.990Pre Close83.08KTurnover0.97%Turnover Ratio0.07P/E (Static)1.27MShares82.00052wk High4.49P/B8.76MFloat Cap6.70052wk Low--Dividend TTM1.20MShs Float22220.000Historical High--Div YieldTTM8.57%Amplitude6.425Historical Low7.096Avg Price1Lot Size
Redhill Biopharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -89.43%6.53M | -90.21%1.8M | -72.54%3.6M | -27.94%61.8M | -42.01%12.8M | -18.77%17.55M | -14.68%18.35M | -36.31%13.1M | 33.25%85.76M | 2.84%22.07M |
| Operating revenue | -89.43%6.53M | -90.21%1.8M | -72.54%3.6M | -27.94%61.8M | -42.01%12.8M | -18.77%17.55M | -14.68%18.35M | -36.31%13.1M | 33.25%85.76M | 2.84%22.07M |
| Cost of revenue | -89.62%3.46M | -91.04%806K | -74.38%1.61M | -32.52%33.34M | -55.53%8.6M | 2.41%9.45M | -15.06%9M | -38.62%6.29M | 33.92%49.41M | 81.51%19.33M |
| Gross profit | -89.21%3.07M | -89.41%990K | -70.83%1.99M | -21.70%28.46M | 53.45%4.2M | -34.56%8.1M | -14.31%9.35M | -34.01%6.81M | 32.34%36.35M | -74.68%2.74M |
| Operating expense | -51.61%34.5M | 161.43%48.39M | -215.58%-27.09M | -39.31%71.31M | -39.63%14.15M | -48.93%15.21M | -48.29%18.51M | -17.68%23.44M | 28.89%117.49M | -23.20%23.44M |
| Selling and administrative expenses | -51.62%30.98M | -52.69%8.06M | -46.48%10.91M | -27.23%64.03M | -25.92%13.02M | -43.25%13.6M | -33.11%17.04M | -2.92%20.38M | 17.85%87.99M | -27.79%17.57M |
| -Selling and marketing expense | -76.87%2.1M | -51.23%4.52M | -59.32%5.11M | -20.44%9.06M | 40.28%-19.87M | -54.31%7.09M | -39.13%9.27M | -9.61%12.56M | 40.42%11.39M | -37.05%-33.27M |
| -General and administrative expense | -47.46%28.88M | -54.44%3.54M | -25.85%5.8M | -28.24%54.97M | -35.32%32.88M | -22.90%6.5M | -24.13%7.77M | 10.19%7.82M | 15.10%76.6M | 4.60%50.84M |
| Research and development costs | -51.53%3.53M | -15.29%1.25M | -64.60%1.08M | -75.32%7.28M | -80.69%1.13M | -72.29%1.61M | -85.75%1.47M | -59.09%3.06M | 78.87%29.5M | -5.19%5.87M |
| Other operating expenses | ---- | ---- | ---39.08M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 26.64%-31.43M | -417.53%-47.4M | 274.88%29.08M | 47.19%-42.84M | 51.94%-9.95M | 59.14%-7.11M | 63.20%-9.16M | 8.39%-16.63M | -27.40%-81.14M | -5.03%-20.7M |
| Net non-operating interest income expense | 94.89%-2.16M | 302.55%5.17M | 642.73%21.16M | -154.55%-42.21M | -96.46%-7.16M | -616.80%-28.59M | 39.74%-2.55M | 17.24%-3.9M | -31.87%-16.58M | 22.56%-3.65M |
| Non-operating interest income | -32.86%94K | 326.90%7.1M | 215,720.00%21.58M | 174.51%140K | -39,450.00%-4.72M | 18,664.71%3.19M | 10,980.00%1.66M | -76.19%10K | -71.02%51K | 107.36%12K |
| Non-operating interest expense | -99.11%367K | -54.30%1.93M | -89.23%421K | 149.49%41.33M | -60.28%1.43M | 693.38%31.78M | -0.85%4.21M | -17.76%3.91M | 33.07%16.57M | -15.36%3.59M |
| Total other finance cost | 85.90%1.89M | ---- | ---- | 1,460.00%1.01M | ---- | ---- | ---- | ---- | -78.33%65K | ---- |
| Other net income (expense) | 330.00%57.54M | 47,892.86%13.38M | -132.94%-28K | |||||||
| Gain on sale of security | -142.47%-5.68M | ---- | ---- | 47,892.86%13.38M | ---- | ---- | ---- | ---- | -132.94%-28K | ---- |
| Special income (charges) | --54.63M | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---19.13M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of business | --35.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | --8.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 133.42%23.95M | 106.50%761K | 344.74%50.24M | 26.68%-71.67M | 84.70%-3.73M | -66.93%-35.7M | 59.79%-11.71M | 10.21%-20.53M | -28.32%-97.74M | -0.17%-24.37M |
| Income tax | ||||||||||
| Net income | 133.37%23.92M | 106.50%761K | 344.74%50.24M | 26.68%-71.67M | 84.70%-3.73M | -66.93%-35.7M | 59.79%-11.71M | 10.21%-20.53M | -28.32%-97.74M | -0.17%-24.37M |
| Net income continuous Operations | 133.42%23.95M | 106.50%761K | 344.74%50.24M | 26.68%-71.67M | 84.70%-3.73M | -66.93%-35.7M | 59.79%-11.71M | 10.21%-20.53M | -28.32%-97.74M | -0.17%-24.37M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 133.37%23.92M | 106.50%761K | 344.74%50.24M | 26.68%-71.67M | 84.70%-3.73M | -66.93%-35.7M | 59.79%-11.71M | 10.21%-20.53M | -28.32%-97.74M | -0.17%-24.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 133.37%23.92M | 106.50%761K | 344.74%50.24M | 26.68%-71.67M | 84.70%-3.73M | -66.93%-35.7M | 59.79%-11.71M | 10.21%-20.53M | -28.32%-97.74M | -0.17%-24.37M |
| Basic earnings per share | 108.33%100 | 102.41%4.8263 | 225.00%500 | 42.86%-1.2K | 0 | -20.00%-600 | 66.67%-200 | 20.00%-400 | 0.00%-2.1K | 28.57%-500 |
| Diluted earnings per share | 108.33%100 | 102.41%4.8263 | 225.00%500 | 42.86%-1.2K | 0 | -20.00%-600 | 66.67%-200 | 20.00%-400 | 0.00%-2.1K | 28.57%-500 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data